Skip to main content
TipRanks
Go Ultimate75% OFF

Evolva Holding (EVE) AI Stock Analysis

3 Followers
CH:EVE

Evolva Holding

(Six Swiss:EVE)

Select Model
Rating:50Neutral
Price Target:CHF 2.50â–²(9.65% Upside)
Action:reiterated
Date:10/13/26

The score is held down primarily by weak financial performance (zero recent revenue and persistent negative operating/free cash flow), with only partial support from a low-debt balance sheet. Technicals are a clear positive (price above key moving averages with positive MACD), but valuation is constrained by negative earnings and no dividend support.

Positive Factors
Low Financial LeverageNo debt from 2023–2025 limits interest-bearing obligations and reduces balance-sheet strain. This gives Evolva greater financial flexibility to preserve resources, pursue its ingredient and biotechnology activities, or withstand operating volatility without added lender pressure.
Negative Factors
Zero Recent RevenueRevenue dropping to zero in both 2024 and 2025 indicates that Evolva currently lacks a durable operating revenue base. Without recurring sales, the company has limited evidence of commercial scale, making future profitability and self-funded growth dependent on rebuilding meaningful business activity.

Evolva Holding (EVE) vs. iShares MSCI Switzerland ETF (EWL)

-50%0%50%100%150%200%250%CH:EVE+174.70%EWL+16.52%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 15.50M
Dividend Yield
―
Average Volume (3M)
41.53K
Price to Earnings (P/E)
-17.7
Beta (1Y)
0.42
Revenue Growth
―
EPS Growth
-39.83%
Country
Switzerland
Employees
49
Sector
Financial
Sector Strength
68
Industry
Shell Companies

Evolva Holding Business Overview & Revenue Model

Company Description

EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søre...

Evolva Holding Financial Statement Overview

Summary

Overall fundamentals are weak. Revenue declined and then fell to zero in 2024–2025, profitability is highly volatile with losses in most years, and operating/free cash flow are negative every year (2020–2025), indicating persistent cash burn. The main offset is a low-debt balance sheet (no debt from 2023–2025) and reduced cash burn in 2024–2025, but these are not enough to counter the lack of durable revenue and cash generation.

Income Statement

18Very Negative

Balance Sheet

58Neutral

Cash Flow

21Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue0009.44M15.54M9.88M
Gross Profit000-4.83M-8.89M-9.31M
EBITDA-775.00K-652.10K3.96M-98.36M-34.52M-31.82M
Net Income-926.70K-652.70K1.04M-105.23M-43.37M-41.27M
Balance Sheet
Total Assets5.57M6.76M7.54M9.83M131.01M156.17M
Cash, Cash Equivalents and Short-Term Investments4.22M5.61M6.75M5.84M5.14M11.00M
Total Debt000015.06M10.84M
Total Liabilities264.10K812.70K945.30K4.28M24.77M24.40M
Stockholders Equity5.31M5.94M6.60M5.55M106.24M131.77M
Cash Flow
Free Cash Flow-2.10M0-2.44M-9.72M-21.13M-33.57M
Operating Cash Flow-2.10M-1.14M-2.44M-9.25M-18.88M-29.79M
Investing Cash Flow003.52M15.95M-1.76M-4.64M
Financing Cash Flow00-163.10K-5.97M14.77M25.72M

Evolva Holding Technical Analysis

Technical Analysis SentimentNeutral
Last Price2.28

Price Trends

50DMA2.25Positive
100DMA2.25Positive
200DMA1.68Positive

Market Momentum

MACD0.01Positive
RSI46.70Neutral
STOCH34.30Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:EVE, the sentiment is Neutral. The current price of 2.28 is below the 20-day moving average (MA) of 2.33, above the 50-day MA of 2.25, and above the 200-day MA of 1.68, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 46.70 is Neutral, neither overbought nor oversold. The STOCH value of 34.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CH:EVE.

Evolva Holding Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

CH:EVE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CH:BANBCH:BANB80OutperformCHF 5.97B39.9710.27%1.13%4.51%11.05%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
CH:LONNCH:LONN67NeutralCHF 45.39B41.81―0.75%-10.77%-114.77%
CH:KURNCH:KURN66NeutralCHF 775.42M107.5710.24%―40.91%―
CH:EVECH:EVE50NeutralCHF 16.45M-17.74-16.47%――-39.83%
CH:MOLNCH:MOLN38UnderperformCHF 96.90M-1.78-79.25%――16.86%

* Financial Sector Average

Performance Comparison

0%100%200%CH:EVECH:MOLNCH:LONNCH:BANBCH:KURNCH:XLSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:EVE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:EVEEvolva Holding Sa2.281.43168.24%
CH:MOLNMolecular Partners2.40-0.91-27.38%
CH:LONNLonza Group666.00142.2927.17%
CH:BANBBachem Holding AG Class B79.5531.4565.38%
CH:KURNKuros Biosciences 19.47-7.41-27.57%
CH:XLSXlife Sciences Ltd.8.48-8.12-48.92%

Evolva Holding Corporate Events

Ascend to Go Public via EvoNext Merger in CHF 500m Sports Tech Deal

Oct 12, 2026

EvoNext Holdings SA and Ascend Sport Technology AG have agreed to merge in a statutory transaction that will take Ascend public via EvoNext’s existing listing on SIX Swiss Exchange, creating a listed Swiss sports technology company with global reach....

EvoNext Posts Modest Loss as Talks Advance on Reverse Merger with Ascend Sport Technology

Sep 30, 2026

EvoNext Holdings SA reported liquidity of CHF 5.5 million and equity of CHF 5.3 million as of 30 June 2026, with a net loss of CHF 0.6 million driven mainly by one-off transaction and search-related costs. The company’s half-year figures highlight a...

EvoNext in advanced talks on reverse merger with AI sports tech firm Ascend

Aug 17, 2026

EvoNext Holdings SA has confirmed it is in advanced talks with Ascend Sport Technology AG over a reverse merger that would bring the profitable, AI-driven Swiss sports technology firm to the SIX Swiss Exchange. The contemplated deal envisages valuing...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 13, 2026